![](/img/cover-not-exists.png)
Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy
D. Chadwick, D. Smith, P. Crawford, B. HarrisonVolume:
9
Year:
2000
Language:
english
DOI:
10.1053/seiz.2000.0448
File:
PDF, 69 KB
english, 2000